Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Mhazo AT;Mhazo AT; Maponga CC; Maponga CC
  • المصدر:
    BMC health services research [BMC Health Serv Res] 2022 Nov 22; Vol. 22 (1), pp. 1390. Date of Electronic Publication: 2022 Nov 22.
  • نوع النشر :
    Journal Article
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Background: Framing affects how issues are understood and portrayed. This profoundly shapes the construction of social problems and how policy options are considered. While access to essential medicines (ATM) in the World Health Organization (WHO) African Region is often framed as a societal problem, there is dominance of medical and technically oriented approaches to analyze and remedy the situation. Hence, the systematic application of social science approaches, such as framing theory, remains under-explored. Through a framing analysis of National Strategic Plans (NSPs) from eight countries, this study explores the applicability and potential usefulness of framing theory to analyze essential medicines policies.
      Methods: We inductively coded the relevant NSP textual fragments using the qualitative content analysis software ATLAS.ti.22. Benford and Snow's conceptualization of framing was used to organize the coded data into three frames: diagnostic (problems), prognostic (solutions) and motivational (values and ideological).
      Results: The following five diagnostic frames were dominant or in-frame: medicine unavailability, ineffective regulation, weak supply chain management, proliferation of counterfeit (substandard or falsified) medicines and use of poor quality medicines. Diagnostic frames related to financing, affordability, efficiency and corruption were given limited coverage or out of frame. Prognostic frames corresponded with how these problems were framed. Whilst Universal Health Coverage (UHC) and its guiding principles was the dominant motivational frame, we identified some frame discordance between the global discourse and national level policies.
      Conclusions: Social science approaches such as framing analysis are applicable and useful to systematically analyze essential medicine aspects. By applying framing theory, we revealed that ATM aspects in the eight countries we analyzed are more often characterized in relation to availability at the expense of affordability which undermines UHC. We conclude that whilst UHC is a strong motivational frame to guide ATM aspects, it is insufficient to inform a comprehensive approach to address the problems related to ATM at country level. To effectively advance ATM, concerned actors need to realize such limitation and endeavor to gain a deeper understanding of how problems are framed and agendas are set at country level, the processes through which ideas and knowledge become policies, including the political demands, incentives and trade-offs facing decision-makers in selecting policy priorities.
      (© 2022. The Author(s).)
    • References:
      PLoS Med. 2021 Apr 22;18(4):e1003604. (PMID: 33886540)
      Antimicrob Agents Chemother. 2020 Aug 20;64(9):. (PMID: 32540971)
      Daru. 2016 May 04;24(1):13. (PMID: 27141958)
      J Health Polit Policy Law. 2017 Oct;42(5):803-839. (PMID: 28663180)
      Health Policy Plan. 2016 Jul;31(6):801-16. (PMID: 26873903)
      Health Policy Plan. 2019 Dec 1;34(Supplement_3):iii1-iii3. (PMID: 31816069)
      Braz J Med Biol Res. 2000 Feb;33(2):179-89. (PMID: 10657057)
      Lancet. 2003 May 17;361(9370):1723-9. (PMID: 12767751)
      Lancet. 2009 Jan 17;373(9659):240-9. (PMID: 19042012)
      Bull World Health Organ. 2010 Jun;88(6):402. (PMID: 20539847)
      BMJ. 2003 Mar 1;326(7387):495-7. (PMID: 12609950)
      Health Policy Plan. 2021 Jun 3;36(5):585-593. (PMID: 33709155)
      Int J Nurs Stud. 2010 Nov;47(11):1451-8. (PMID: 20598692)
      J Infect Dev Ctries. 2011 Feb 01;5(1):48-53. (PMID: 21330740)
      Lancet. 2020 Dec 5;396(10265):1790-1791. (PMID: 33278923)
      Int J Health Policy Manag. 2018 Dec 22;8(4):191-194. (PMID: 31050963)
      Methods Mol Biol. 2009;572:3-12. (PMID: 20694682)
      Health Hum Rights. 2017 Dec;19(2):117-122. (PMID: 29302169)
      J Health Polit Policy Law. 2006 Feb;31(1):51-70. (PMID: 16484668)
      Glob Health Action. 2020;13(sup1):1694745. (PMID: 32194011)
      Implement Sci. 2010 May 26;5:39. (PMID: 20504357)
      Health Policy Plan. 2021 Feb 16;35(10):1424-1431. (PMID: 33175972)
      PLoS Med. 2010 Aug 31;7(8):. (PMID: 20824175)
      PLoS One. 2019 Jun 28;14(6):e0215577. (PMID: 31251737)
      Health Policy Plan. 2020 Apr 1;35(3):364-372. (PMID: 31904858)
      Health Policy Plan. 2012 Dec;27(8):625-37. (PMID: 22345671)
      Health Policy Plan. 2019 Sep 1;34(7):529-543. (PMID: 31377775)
      Lancet. 2017 Jan 28;389(10067):403-476. (PMID: 27832874)
      Cien Saude Colet. 2017 Aug;22(8):2435-2439. (PMID: 28793061)
      Am J Public Health. 2004 Nov;94(11):1864-74. (PMID: 15514221)
      BMJ. 2004 Nov 13;329(7475):1169-72. (PMID: 15539676)
      J Am Med Assoc. 1946 Apr 20;130:1069. (PMID: 21019115)
      Cad Saude Publica. 2007;23 Suppl 1:S85-96. (PMID: 17308722)
      Health Res Policy Syst. 2021 May 3;19(1):72. (PMID: 33941199)
      Int J Health Serv. 2016;46(2):346-65. (PMID: 26883181)
      Front Med (Lausanne). 2017 Dec 07;4:218. (PMID: 29270407)
      Bull World Health Organ. 2011 Jun 1;89(6):412-21. (PMID: 21673857)
      World Health Organ Tech Rep Ser. 1977;(615):1-36. (PMID: 414461)
      Lancet. 2007 Oct 13;370(9595):1370-9. (PMID: 17933652)
      BMC Public Health. 2014 Jan 21;14:63. (PMID: 24447600)
      J Pharm Policy Pract. 2015 Feb 16;8(1):8. (PMID: 25825675)
      J Family Med Prim Care. 2015 Jul-Sep;4(3):324-7. (PMID: 26288766)
    • Contributed Indexing:
      Keywords: Access to essential medicines; Framing; National strategic plan; WHO African Region
    • الرقم المعرف:
      0 (Drugs, Essential)
    • الموضوع:
      Date Created: 20221124 Date Completed: 20221125 Latest Revision: 20221213
    • الموضوع:
      20240513
    • الرقم المعرف:
      PMC9682662
    • الرقم المعرف:
      10.1186/s12913-022-08791-9
    • الرقم المعرف:
      36419062